Glaxosmithkline, LLC
Federal Contractor · Rank #1219
Glaxosmithkline, LLC Federal Spending Profile
Glaxosmithkline, LLC is a smaller federal recipient, with $62.7M in total federal obligations across 25 awards in the USAspending.gov record. That places Glaxosmithkline, LLC #1219 among federal contractors ranked by total obligations.
Every one of Glaxosmithkline, LLC's 25 federal awards is a procurement contract rather than a grant — the company sells goods or services to the government rather than receiving grant funding.
Glaxosmithkline, LLC's federal business is heavily concentrated in one customer: Department of Health and Human Services accounts for roughly 99% of its top-agency obligations, with Department of Defense a distant second. Across the full record the company works with 2 agencies, but a single relationship dominates the dollars.
What the federal government buys from Glaxosmithkline, LLC is led by Other Services ($148.4M), followed by Healthcare & Medical ($50.9M); together these categories describe the goods and services the company is paid to deliver.
Its largest single recent award is a $18.2M contract from the Department of Health and Human Services, described in the federal record as "As03b-H7n9 Vaccine Clinical Study."
Track Glaxosmithkline, LLC
Subscribe for TaxDollarData updates by email. No spam, unsubscribe anytime.
Spending by Agency
Recent Awards
| Description | Agency | Start Date | Amount |
|---|---|---|---|
| THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT # 75A50122D00002 BASE PERIOD. | Department of Health and Human Services | Sep 14, 2022 | $22.9M |
| THIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES PREPAREDNESS AND RESPONSE UNDER CONTRACT 75A50122D00002. | Department of Health and Human Services | May 10, 2024 | $18.2M |
| AS03B-H7N9 VACCINE CLINICAL STUDY | Department of Health and Human Services | Aug 28, 2019 | $18.2M |
| IGF::OT::IGF 2016 VFA - GSK | Department of Health and Human Services | Jul 1, 2016 | $16.4M |
| COMMERCIAL BULK LOTS | Department of Health and Human Services | May 19, 2017 | $15.8M |
| THE PURPOSE OF THIS TASK ORDER IS TO ESTABLISH FILL/FINISH ACTIVITIES FOR ADJUVANT (AS03) TO SUPPORT THE COVID-19 FEDERAL RESPONSE- MULTI-DOSE VIALS FOR HHS UNDER IDIQ CONTRACT #75A50122D00002. | Department of Health and Human Services | Feb 27, 2024 | $15.4M |
| THE PURPOSE OF THIS HHS TASK ORDER IS TO PROCURE SERVICES FOR THE STORAGE AND STABILITY OF BULK LOTS & FINAL CONTAINERS OF-ADJUVANT( AS03) COVID-19 FUNDS. | Department of Health and Human Services | Feb 21, 2024 | $14.0M |
| THIS TASK ORDER ESTABLISHES SERVICES FOR STORAGE AND STABILITY OF AS03 ADJUVANT MANUFACTURED TO SUPPORT THE COVID-19 FEDERAL RESPONSE IN BULK LOTS AND FINAL CONTAINERS FOR THE LIFE OF THE MATERIAL. ALL OPTION PERIODS ARE HEREBY EXERCISED UNDER THIS | Department of Health and Human Services | Jun 17, 2024 | $11.5M |
| RELENZA (ZANAMIVIR) ROTADISK, SMG, NDC 00173-0681-22 | Department of Health and Human Services | Aug 17, 2023 | $8.7M |
| ON BEHALF OF DOD DHA: MANUFACTURE 1 BULK LOT AS03 | Department of Health and Human Services | Sep 24, 2019 | $8.4M |
| THE PURPOSE OF THIS TASK ORDER IS TO PROCURE STORAGE AND STABILITY FOR ANTIGENS AND ADJUVANTS FROM PRIOR CONTRACTS FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D000002 DURING BASE PERIOD YR. 3. PERIOD OF PERFORMANCE: FEBRUARY | Department of Health and Human Services | Feb 21, 2024 | $7.8M |
| ASPR-13-08975 | Department of Health and Human Services | Aug 16, 2013 | $7.2M |
| STORAGE AND STABILITY OF INFLUENZA VACCINE STOCKPILE | Department of Health and Human Services | Jun 21, 2019 | $5.5M |
| PURPOSE OF THIS MODIFICATION IS TO: 1. ACCEPT TRANSFER ACCOUNTABILITY OF 5,015,690 VIALS (50.1 MILLION DOSES) OF AS03 ADJUVANT FROM CONTRACT # W15QKN-20-C-0048 TO CONTRACT # 75A50122D00002 2. ADD FUNDING IN THE AMOUNT OF $1,038,708.00 FOR 33 BUL | Department of Health and Human Services | Dec 12, 2022 | $4.7M |
| FUNDING FOR ACQUISITION OF MCM AND PANDEMIC INFLUENZA PREPAREDNESS AND RESPONSE UNDER NEW SOLICITATION HHS-BARDA-11-100-SOL-00020 (COMPANY C) | Department of Health and Human Services | Sep 1, 2012 | $4.0M |
| ASPR-15-04171 -- GSK STORAGE OF H5N1 ANTIGEN BULK LOTS AND FINAL CONTAINERS AND ADJUVANT BULK LOTS AND FINAL CONTAINERS FOR CY2015 UNDER CONTRACT HHSO100201200013I | Department of Health and Human Services | Apr 3, 2015 | $3.0M |
| DELIVERY ORDER FOR ANNUAL FLU VACCINES FROM GLAXOSMITHKLINE LLC | Department of Health and Human Services | May 31, 2024 | $2.8M |
| ASPR-13-06567 -- GSK-CLIN 003 CGMP INFLUENZA VACCINE CLINICAL LOT UNDER CONTRACT HHSO100201200013I | Department of Health and Human Services | May 30, 2013 | $2.8M |
| GSK VACCINES STORAGE AND ROTATION CONTRACT | Department of Health and Human Services | Aug 15, 2023 | $2.1M |
| THE PURPOSE OF THIS TASK ORDER IS TO PROCURE STORAGE AND STABILITY OF ANTIGENS AND ADJUVANTS FROM PRIOR CONTRACTS FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT 75A50122D00002 DURING BASE PERIOD YEAR 2. | Department of Health and Human Services | Feb 22, 2023 | $2.0M |
All federal spending data sourced from USAspending.gov, the official source for federal award data as mandated by the Government Accountability Office.
Glaxosmithkline, LLC Federal Contracts FAQ
Glaxosmithkline, LLC has received $62,728,478 in total federal obligations across 25 awards and 25 contracts.
Glaxosmithkline, LLC works with 2 federal agencies, including Department of Health and Human Services, Department of Defense. The largest agency relationships are based on total dollar obligations.
Glaxosmithkline, LLC has received federal awards in multiple states.
Glaxosmithkline, LLC is ranked #1219 among the largest federal contractors by total obligation amount. Rankings are based on USASpending.gov data for FY2024.
Explore Other Federal Contractors
Spending figures represent total federal obligations for FY2024, as reported through USASpending.gov. Rankings are based on aggregate obligation amounts across all contract, grant, and direct payment awards.